Not applicableStudy completedNCT03238443What this trial is testingInterest of the Donor-specific Antibodies After Liver TransplantationWho this might be right forLiver Transplant University Hospital, Lille 120
Large-scale testing (Phase 3)Looking for participantsNCT05385432What this trial is testingInduction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDiesWho this might be right forRenal Transplant RejectionInduction Therapy University Hospital, Tours 244
Early research (Phase 1)Ended earlyNCT01848301What this trial is testingEndothelial Injury and Development of Coronary Intimal Thickening After Heart TransplantationWho this might be right forCardiac Allograft VasculopathyAntibody Mediated Rejection Gladwin, Mark, MD 12
Testing effectiveness (Phase 2)Ended earlyNCT03591380What this trial is testingCAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant RecipientsWho this might be right forKidney Transplantation University of Wisconsin, Madison 3
Not applicableStudy completedNCT06395220What this trial is testingKinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell TransplantationWho this might be right forHaematological Malignancy Peking University People's Hospital 314
Testing effectiveness (Phase 2)Active Not RecruitingNCT03991780What this trial is testingFostamatinib in the Treatment of Chronic Active Antibody Mediated RejectionWho this might be right forRenal Transplant Rejection Imperial College London 8
Not applicableNot Yet RecruitingNCT07718308What this trial is testingCD38 mAb Induction + Azathioprine Maintenance for Chronic Active AMR in Kidney Transplant RecipientsWho this might be right forKidney TransplantationAntibody-mediated Rejection wujianyong 20
Not applicableStudy completedNCT02633826What this trial is testingPre-formed Alloreactivity in Renal Transplant RecipientsWho this might be right forKidney TransplantationAcute Graft Rejection Martina Sester 190
Large-scale testing (Phase 3)Study completedNCT02013037What this trial is testingThe De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac TransplantationWho this might be right forAntibody-mediated RejectionHyperacute Rejection of Cardiac TransplantLeft Ventricular Dysfunction+2 more Cedars-Sinai Medical Center 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07698080What this trial is testingDexamethasone, Intravenous Injection of Human Immunoglobulin, and Increased Infusion of Mononuclear Cells to Reduce Donor Specific Antibodies in Haploidentical Hematopoietic Stem Cell TransplantationWho this might be right forLeukemiaLymphomaThalassemia+2 more Hematology department of the 920th hospital 60
Not applicableStudy completedNCT05431712What this trial is testingImpact of Donor-Specific Antibodies in (Highly-) Immunized Living Donor Kidney Transplant RecipientsWho this might be right forRenal Failure Erasmus Medical Center 252
Testing effectiveness (Phase 2)UnknownNCT02563340What this trial is testingEffect of BM-MSCs on Chronic AMR After Kidney TransplantationWho this might be right forKidney Transplantation First Affiliated Hospital, Sun Yat-Sen University 60
Post-approval studies (Phase 4)Active Not RecruitingNCT07274462What this trial is testingDARA-MVI Study (Daratumumab for Microvascular Inflammation in Kidney Transplantation)Who this might be right forMicrovascular Inflammation - MVI in Kindey Transplant Recipients University Hospital, Martin 20
Testing effectiveness (Phase 2)Study completedNCT01178216What this trial is testingUse of Immune Globulin Plus Rituximab for Desensitization in Highly HLA Sensitized Patients Awaiting Deceased Donor Kidney TransplantationWho this might be right forEnd Stage Renal Disease Stanley Jordan, MD 41
Post-approval studies (Phase 4)Study completedNCT04225988What this trial is testingComparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant RecipientsWho this might be right forKidney Transplant Rejection Cedars-Sinai Medical Center 20
Large-scale testing (Phase 3)Looking for participantsNCT04877288What this trial is testingEvaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive MedicationsWho this might be right forRenal Allograft Recipients Bristol-Myers Squibb 102
Post-approval studies (Phase 4)Study completedNCT02284464What this trial is testingSteroid Withdrawal and Donor-specific Anti-HLA Antibodies in Renal Transplant PatientsWho this might be right forOther Complication of Kidney TransplantRenal Transplant Rejection Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 230
Not applicableUnknownNCT06177561What this trial is testingSafety and Efficacy of LPE in Clearing DSA in Patients Who Received Allo-HSCTWho this might be right forLeukemia Ruijin Hospital 38
Post-approval studies (Phase 4)UnknownNCT04404127What this trial is testingStandard Induction With Basiliximab Versus No-Induction in Low Immunological Risk Kidney Transplant RecipientsWho this might be right forKidney Transplantation King Faisal Specialist Hospital & Research Center 140
Early research (Phase 1)WithdrawnNCT00476515What this trial is testingRituximab Therapy for Patients on Kidney Transplant Waiting List With Positive Donor Specific Crossmatch to Living DonorWho this might be right forKidney Insufficiency Massachusetts General Hospital